Follow on Google News News By Tag * Pharma Partnering * Molecular Diagnostics * Infectious Diseases * Therapeutics * Diagnostic Partnering * vc * Chi * Cancer * More Tags... Industry News News By Place Country(s) Industry News
Follow on Google News | CHI's Pharma-Bio Partnering Forum: Emerging Diagnostic Partnering & Investment, August 19, 2012, DCThis event will take place prior to the start of the Next Generation Dx Summit: Moving Assays to Clinic (August 21-23).
LEARN about the latest tools, platforms and applications in molecular diagnostics HEAR from innovative technology developers working in cancer, infectious disease and other therapeutic areas DISCUSS strategies to leverage alliances and partnerships to bring diagnostics to market NETWORK with early stage companies, established diagnostic and platform companies, clinical labs and investors EXPLORE potential partnership opportunities through one-on-one meetings MAXIMIZE your experience on site with Partner Direct networking software View the agenda and register at http://www.NextGenerationDx.com/ As part of the Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Mass Spec for the Clinic), this event will bring together all of the major players in the evolving areas of diagnostics. To inquire about sponsorship/ About Cambridge Healthtech Institute (www.chicorporate.com) CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and eCliniqua. Founded in 1992, CHI strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Contact: James Prudhomme Cambridge Healthtech Institute 781-972-5400 jprudhomme@healthtech.com End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|